Literature DB >> 28177492

Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study.

Jennifer E Schuster1, Hannah L Palac2, Nancy Innocentini3, Anne H Rowley3, Luciana T Young3, Stanford T Shulman3.   

Abstract

Kawasaki disease (KD) shock syndrome (KDSS) is hypotension with KD. We compared children with KDSS and matched control children with KD. Children with KDSS more often were female, had a lower platelet count and sodium concentration, had a condition refractory to immunoglobulin, and had abnormal echocardiography results. KDSS is a unique subset of KD.
© The Author 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Kawasaki disease; hyponatremia; hypotension; shock

Mesh:

Substances:

Year:  2017        PMID: 28177492     DOI: 10.1093/jpids/piw081

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  4 in total

1.  Kawasaki disease shock syndrome: A report of two cases and literature review.

Authors:  Qingyou Zhang; Ying Liao; Junbao Du
Journal:  Pediatr Investig       Date:  2019-06-25

2.  The incidence, hospitalisations and deaths in acutely ill children with dysnatraemias.

Authors:  Saara Lehtiranta; Minna Honkila; Silja Anttila; Heikki Huhtamäki; Tytti Pokka; Terhi Tapiainen
Journal:  Acta Paediatr       Date:  2022-04-08       Impact factor: 4.056

3.  Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.

Authors:  Usha Sethuraman; Nirupama Kannikeswaran; Jocelyn Ang; Adam Singer; Jason Miller; Rita Haddad; Curt Stankovic
Journal:  Am J Emerg Med       Date:  2020-10-24       Impact factor: 4.093

4.  Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.

Authors:  Saori Fukui; Mitsuru Seki; Takaomi Minami; Kazuhiko Kotani; Kensuke Oka; Akiko Yokomizo; Daisuke Matsubara; Tomoyuki Sato; Yasuyuki Nozaki; Mari Saito; Yutaka Kikuchi; Kenji Miyamoto; Yukifumi Monden; Takanori Yamagata
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-03       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.